Van Zyl GU - Search Results

1

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.

Van Zyl GU, Liu TF, Claassen M, Engelbrecht S, de Oliveira T, Preiser W, Wood NT, Travers S, Shafer RW. Van Zyl GU, et al. PLoS One. 2013 Jun 26;8(6):e67188. doi: 10.1371/journal.pone.0067188. Print 2013. PLoS One. 2013. PMID: 23840622 Free PMC article.

2

Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa.

Claassen M, van Zyl GU, Korsman SN, Smit L, Cotton MF, Preiser W. Claassen M, et al. Among authors: van zyl gu. J Clin Virol. 2006 Sep;37(1):68-71. doi: 10.1016/j.jcv.2006.06.008. Epub 2006 Jul 27. J Clin Virol. 2006. PMID: 16875874

3

Extraction buffer contaminated bacterially as a cause of invalid HIV-1 viral load results on the NucliSens EasyQ system.

Claassen M, van Zyl GU, Preiser W. Claassen M, et al. Among authors: van zyl gu. J Virol Methods. 2008 Jun;150(1-2):80-1. doi: 10.1016/j.jviromet.2008.03.004. Epub 2008 Apr 18. J Virol Methods. 2008. PMID: 18423634

4

Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.

van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, Theron GB, Preiser W. van Zyl GU, et al. J Med Virol. 2008 Jun;80(6):942-6. doi: 10.1002/jmv.21157. J Med Virol. 2008. PMID: 18428139

5

Protease inhibitor resistance in South African children with virologic failure.

van Zyl GU, van der Merwe L, Claassen M, Cotton MF, Rabie H, Prozesky HW, Preiser W. van Zyl GU, et al. Among authors: van der merwe l. Pediatr Infect Dis J. 2009 Dec;28(12):1125-7. doi: 10.1097/INF.0b013e3181af829d. Pediatr Infect Dis J. 2009. PMID: 19779394

6

Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa.

van Zyl GU, Cotton MF, Claassen M, Abrahams C, Preiser W. van Zyl GU, et al. Pediatr Infect Dis J. 2010 Apr;29(4):370-1. doi: 10.1097/INF.0b013e3181c4dada. Pediatr Infect Dis J. 2010. PMID: 19935449

7

NucliSens EasyQ HIV-1 V1.2 system: Detection of human plasma-derived background signal.

van Zyl GU, Korsman SN, Maree L, Preiser W. van Zyl GU, et al. J Virol Methods. 2010 May;165(2):318-9. doi: 10.1016/j.jviromet.2010.02.023. Epub 2010 Feb 26. J Virol Methods. 2010. PMID: 20219541

8

Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.

Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, Moulton LH, Welte A, Humphrey J. Marinda ET, et al. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):496-9. doi: 10.1097/qai.0b013e3181b61938. J Acquir Immune Defic Syndr. 2010. PMID: 20306555

9

Young age a predictor of weak reactivity in a rapid antibody test in infants infected with HIV.

Maree L, van Zyl GU, Lotter SL, de Beer C, Esser MM, Preiser W. Maree L, et al. Among authors: van zyl gu. J Med Virol. 2010 Aug;82(8):1314-7. doi: 10.1002/jmv.21832. J Med Virol. 2010. PMID: 20572089

10

Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.

van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G. van Zyl GU, et al. Among authors: van der merwe l, van mens te. J Acquir Immune Defic Syndr. 2011 Apr;56(4):333-9. doi: 10.1097/QAI.0b013e31820dc0cc. J Acquir Immune Defic Syndr. 2011. PMID: 21239995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters